Antibiotics
are lifesaving drugs, but overuse is leading to antibiotic resistance, one of
the world's most pressing health threats. Scientists identified 11 genetic
markers in blood that accurately distinguished between viral and bacterial
infections 80 to 90 percent of the time. The finding is important because
physicians don't have a good way to confirm bacterial infections like pneumonia
and more-often-than-not default to an antibiotic.
Scientists
from the University's National Institutes of Health-funded Respiratory
Pathogens Research Center identified 11 genetic markers in blood that
accurately distinguished between viral and bacterial infections (antibiotics
help us fight bacterial infections, but aren't effective and shouldn't be used
to treat viruses). The finding, published in the journal Scientific Reports, is
important because physicians don't have a good way to confirm bacterial
infections like pneumonia and more-often-than-not default to an antibiotic.
"It's
extremely difficult to interpret what's causing a respiratory tract infection,
especially in very ill patients who come to the hospital with a high fever,
cough, shortness of breath and other concerning symptoms," said Ann R.
Falsey, M.D., lead study author, professor and interim chief of the Infectious
Diseases Division at UR Medicine's Strong Memorial Hospital. "My goal is
to develop a tool that physicians can use to rule out a bacterial infection
with enough certainty that they are comfortable, and their patients are
comfortable, foregoing an antibiotic."
Falsey's
project caught the attention of the federal government; she's one of 10
semifinalists in the Antimicrobial Resistance Diagnostic Challenge, a
competition sponsored by NIH and the Biomedical Advanced Research and
Development Authority to help combat the development and spread of drug
resistant bacteria. Selected from among 74 submissions, Falsey received $50,000
to continue her research and develop a prototype diagnostic test, such as a
blood test, using the genetic markers her team identified.
A
group of 94 adults hospitalized with lower respiratory tract infections were
recruited to participate in Falsey's study. The team gathered clinical data,
took blood from each patient, and conducted a battery of microbiologic tests to
determine which individuals had a bacterial infection (41 patients) and which
had a non-bacterial or viral infection (53 patients). Thomas J. Mariani, Ph.D.,
professor of Pediatrics and Biomedical Genetics at URMC, used complex genetic
and statistical analysis to pinpoint markers in the blood that correctly
classified the patients with bacterial infections 80 to 90 percent of the time.
"Our
genes react differently to a virus than they do to bacteria," said
Mariani, a member of the Respiratory Pathogens Research Center (RPRC).
"Rather than trying to detect the specific organism that's making an
individual sick, we're using genetic data to help us determine what's affecting
the patient and when an antibiotic is appropriate or not."
Falsey,
co-director of the RPRC, and Mariani say that the main limitation of their
study is the small sample size and that the genetic classifiers selected from
the study population may not prove to be universal to all patients.
A
patent application has been filed for their method of diagnosing bacterial
infection. Edward Walsh, M.D., professor of Infectious Diseases, and Derick
Peterson, Ph.D., professor of Biostatics and Computational Biology at URMC,
also contributed to the research.
According
to the Centers for Disease Control and Prevention, antibiotic resistant
bacteria cause at least 2 million infections and 23,000 deaths each year in the
United States. The use of antibiotics is the single most important factor leading
to antibiotic resistance around the world.
See:
No comments:
Post a Comment
Pharmaceutical Microbiology Resources